Results 241 to 247 of about 696,455 (247)

STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus

New England Journal of Medicine, 2007
Paul I W de Bakker, Lars Klareskog, Matthew G. Booty   +2 more
exaly  

Rheumatoid Arthritis — Pathophysiology and Implications for Therapy

New England Journal of Medicine, 1990
Edward Harris, Franklin H Epstein, E D Harris   +2 more
exaly  

Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis

New England Journal of Medicine, 2012
Joel M Kremer, Hendrik Schulze-Koops, Gene Wallenstein   +2 more
exaly  

Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

New England Journal of Medicine, 2017
Michael E Weinblatt, Edward Keystone, Sergey Yakushin   +2 more
exaly  

TRAF1–C5 as a Risk Locus for Rheumatoid Arthritis — A Genomewide Study

New England Journal of Medicine, 2007
Mark Seielstad, Sven Pettersson, Lars Klareskog   +2 more
exaly  

Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition

New England Journal of Medicine, 2005
Mark C Genovese, Joel M Kremer, Richard Aranda   +2 more
exaly  

The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis

New England Journal of Medicine, 1995
John R. Kirwan
exaly